Tag Archives: USPTO

Q. Todd Dickinson Resigns as Executive Director of AIPLA

Posted on July 14, 2014 by Warren Woessner

After six years as AIPLA Executive Director, Q. Todd Dickinson has announced that he will step down. While he was an effective leader at AIPLA, Todd (the “Q” doesn’t stand for anything) made his mark as the first effective Director … Continue reading →

Posted in People | Tagged , , , | Leave a comment

Myriad Guidance Comments

Posted on July 10, 2014 by Warren Woessner

The USPTO is now publishing comments http://www.uspto.gov/patents/law/comments/myriad-mayo_guidance_comments.jsp  

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , | 1 Comment

More Questions Than Answers from the PTO

Posted on July 2, 2014 by Warren Woessner

At the recent BIO International Convention, Deputy Commissioner Andrew Hirschfeld (who chaired the May PTO s.101 Forum) presented seven “Sample Claims” related to biotech/pharma inventions and invited “discussion and feedback” from the interested public. The claims have been posted on … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 1 Comment

URGENT – COMMENTS DEADLINE EXTENDED

Posted on June 27, 2014 by Warren Woessner

The deadline for Myriad-Mayo comments has been extended by a month. Info on the USPTO website and can be found here.  

Posted in USPTO Practice and Policy | Tagged , , , , , , , , | Leave a comment